HMGB1 links chronic liver injury to progenitor responses and hepatocarcinogenesis
Open accessThe DOI matches its Crossref record; 83 of the 85 references it cites were found in a registry or an index.
Abstract
Cell death is a key driver of disease progression and carcinogenesis in chronic liver disease (CLD), highlighted by the well-established clinical correlation between hepatocellular death and risk for the development of cirrhosis and hepatocellular carcinoma (HCC). Moreover, hepatocellular death is sufficient to trigger fibrosis and HCC in mice. However, the pathways through which cell death drives CLD progression remain elusive. Here, we tested the hypothesis that high-mobility group box 1 (HMGB1), a damage-associated molecular pattern (DAMP) with key roles in acute liver injury, may link cell death to injury responses and hepatocarcinogenesis in CLD. While liver-specific HMGB1 deficiency did not significantly affect chronic injury responses such as fibrosis, regeneration, and inflammation, it inhibited ductular/progenitor cell expansion and hepatocyte metaplasia. HMGB1 promoted ductular expansion independently of active secretion in a nonautonomous fashion, consistent with its role as a DAMP. Liver-specific HMGB1 deficiency reduced HCC development in 3 mouse models of chronic injury but not in a model lacking chronic liver injury. As with CLD, HMGB1 ablation reduced the expression of progenitor and oncofetal markers, a key determinant of HCC aggressiveness, in tumors. In summary, HMGB1 links hepatocyte death to ductular reaction, progenitor signature, and hepatocarcinogenesis in CLD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
2 retracted
Yang, H., Lundbäck, P., Ottosson, L., Erlandsson-Harris, H., Venereau, E., Bianchi, M. E., Al-Abed, Y., Andersson, U., Tracey, K. J., & Antoine, D. J. (2012) · Molecular Medicine · doi:10.2119/molmed.2011.00389 · Cited by 407 · cited 1×
“(80) for the indicated durations (Figure 5, B–F and H; Supplemental Fig-”
BackgroundSelf-citationRetractedAntoine, D. J., Jenkins, R. E., Dear, J. W., Williams, D. P., McGill, M. R., Sharpe, M. R., Craig, D. G., Simpson, K. J., Jaeschke, H., & Park, B. K. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.12.019 · Cited by 309
Self-citationRetractedLozano, R., Naghavi, M., Foreman, K., Lim, S., Shibuya, K., Aboyans, V., Abraham, J., Adair, T., Aggarwal, R., Ahn, S. Y., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61728-0 · Cited by 14,070
A scaling normalization method for differential expression analysis of RNA-seq data
Robinson, M. D., & Oshlack, A. (2010) · Genome Biology · doi:10.1186/gb-2010-11-3-r25 · Cited by 7,876 · cited 1×
“with the trimmed mean of M values method (TMM) (79).”
MethodMizgerd, J. P., Kubo, H., Kutkoski, G. J., Bhagwan, S. D., Scharffetter-Kochanek, K., Beaudet, A. L., & Doerschuk, C. M. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.8.1357 · Cited by 7,306
Release of chromatin protein HMGB1 by necrotic cells triggers inflammation
Scaffidi, P., Misteli, T., & Bianchi, M. E. (2002) · Nature · doi:10.1038/nature00858 · Cited by 4,221
El-Serag, H. B. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1001683 · Cited by 3,529
Templeton, A. J., McNamara, M. G., Šeruga, B., Vera-Badillo, F. E., Aneja, P., Ocaña, A., Leibowitz-Amit, R., Sonpavde, G., Knox, J. J., Tran, B., et al. (2014) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dju124 · Cited by 2,829 · cited 1×
“8D), a cell population that contributes role to the development of liver cancer (60), and whose numbers positively correlate with worse prognosis (61, 62), in HCC.”
BackgroundLong-Term Culture of Genome-Stable Bipotent Stem Cells from Adult Human Liver
Huch, M., Gehart, H., van Boxtel, R., Hamer, K., Blokzijl, F., Verstegen, M. M. A., Ellis, E., van Wenum, M., Fuchs, S. A., de Ligt, J., et al. (2015) · Cell · doi:10.1016/j.cell.2014.11.050 · Cited by 1,619
Promotion of Hepatocellular Carcinoma by the Intestinal Microbiota and TLR4
Dapito, D. H., Mencin, A., Gwak, G.-Y., Pradere, J.-P., Jang, M.-K., Mederacke, I., Caviglia, J. M., Khiabanian, H., Adeyemi, A., Bataller, R., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.007 · Cited by 1,346 · cited 2×
“the size of the largest tumor with a caliper, respectively (57).”
BackgroundSelf-citationMonocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion
Bonaldi, T. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg516 · Cited by 1,249
Intravascular Danger Signals Guide Neutrophils to Sites of Sterile Inflammation
McDonald, B., Pittman, K., Menezes, G. B., Hirota, S. A., Slaba, I., Waterhouse, C. C. M., Beck, P. L., Muruve, D. A., & Kubes, P. (2010) · Science · doi:10.1126/science.1195491 · Cited by 1,210
A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells
Lee, J.-S., Heo, J., Libbrecht, L., Chu, I.-S., Kaposi-Novak, P., Calvisi, D. F., Mikaelyan, A., Roberts, L. R., Demetris, A. J., Sun, Z., et al. (2006) · Nature Medicine · doi:10.1038/nm1377 · Cited by 953
Zhou, D., Conrad, C., Xia, F., Park, J.-S., Payer, B., Yin, Y., Lauwers, G. Y., Thasler, W., Lee, J. T., Avruch, J., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.09.026 · Cited by 913 · cited 1×
“As YAP and Notch are well-established and powerful signals driving hepatocyte metaplasia toward a ductular phenotype in adult livers (24, 52) as well as hepatocarcinogenesis (53), we determined whether HMGB1 could act through these pathways.”
BackgroundHippo Pathway Activity Influences Liver Cell Fate
Yimlamai, D., Christodoulou, C., Galli, G. G., Yanger, K., Pepe-Mooney, B., Gurung, B., Shrestha, K., Cahan, P., Stanger, B. Z., & Camargo, F. D. (2014) · Cell · doi:10.1016/j.cell.2014.03.060 · Cited by 857
Cell Death and Cell Death Responses in Liver Disease: Mechanisms and Clinical Relevance
Luedde, T., Kaplowitz, N., & Schwabe, R. F. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.07.018 · Cited by 759 · cited 5×
“Cell death is a key component of CLD and considered an important driver of progression to fibrosis, cirrhosis, and HCC (3).”
BackgroundInfluentialSelf-citationBoulter, L., Govaere, O., Bird, T. G., Radulescu, S., Ramachandran, P., Pellicoro, A., Ridgway, R. A., Seo, S. S., Spee, B., Van Rooijen, N., et al. (2012) · Nature Medicine · doi:10.1038/nm.2667 · Cited by 747
Mutually exclusive redox forms of HMGB1 promote cell recruitment or proinflammatory cytokine release
Venereau, E., Casalgrandi, M., Schiraldi, M., Antoine, D. J., Cattaneo, A., De Marchis, F., Liu, J., Antonelli, A., Preti, A., Raeli, L., et al. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20120189 · Cited by 720
Self-citationEpCAM and α-Fetoprotein Expression Defines Novel Prognostic Subtypes of Hepatocellular Carcinoma
Yamashita, T., Forgues, M., Wang, W., Kim, J. W., Ye, Q., Jia, H., Budhu, A., Zanetti, K. A., Chen, Y., Qin, L.-X., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6013 · Cited by 717 · cited 5×
“High expression of these markers, reflecting poorly differentiated and stem cell-enriched tumors, has been correlated with poor clinical prognosis in a wide body of literature (29-36).”
BackgroundInfluentialMice lacking neutrophil elastase reveal impaired host defense against gram negative bacterial sepsis
Belaaouaj, A., McCarthy, R., Baumann, M., Gao, Z., Ley, T. J., Abraham, S. N., & Shapiro, S. D. (1998) · Nature Medicine · doi:10.1038/nm0598-615 · Cited by 691
DAMPs from Cell Death to New Life
Vénéreau, E., Ceriotti, C., & Bianchi, M. E. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00422 · Cited by 666
Sterile inflammation in the liver
Kubes, P., & Mehal, W. Z. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.09.008 · Cited by 666
Lotze, M. T., Zeh, H. J., Rubartelli, A., Sparvero, L. J., Amoscato, A. A., Washburn, N. R., DeVera, M. E., Liang, X., Tör, M., & Billiar, T. (2007) · Immunological Reviews · doi:10.1111/j.1600-065x.2007.00579.x · Cited by 641
Glycyrrhizin Binds to High-Mobility Group Box 1 Protein and Inhibits Its Cytokine Activities
Mollica, L., De Marchis, F., Spitaleri, A., Dallacosta, C., Pennacchini, D., Zamai, M., Agresti, A., Trisciuoglio, L., Musco, G., & Bianchi, M. E. (2007) · Chemistry & Biology · doi:10.1016/j.chembiol.2007.03.007 · Cited by 612 · cited 1×
“Glycyrrhizin, a phytochemical that inhibits HMGB1 (71), is widely used for”
Deletion of NEMO/IKKγ in Liver Parenchymal Cells Causes Steatohepatitis and Hepatocellular Carcinoma
Luedde, T., Beraza, N., Kotsikoris, V., van Loo, G., Nenci, A., De Vos, R., Roskams, T., Trautwein, C., & Pasparakis, M. (2007) · Cancer Cell · doi:10.1016/j.ccr.2006.12.016 · Cited by 597
A reproducible and well-tolerated method for 2/3 partial hepatectomy in mice
Mitchell, C., & Willenbring, H. (2008) · Nature Protocols · doi:10.1038/nprot.2008.80 · Cited by 577
Bipotential Adult Liver Progenitors Are Derived from Chronically Injured Mature Hepatocytes
Tarlow, B. D., Pelz, C., Naugler, W. E., Wakefield, L., Wilson, E. M., Finegold, M. J., & Grompe, M. (2014) · Cell Stem Cell · doi:10.1016/j.stem.2014.09.008 · Cited by 533 · cited 8×
“Consistent with previous studies (24, 25), we found via lineage tracing with AAV8-TBG-Cre that hepatocytes undergo ductular metaplasia, as seen by coexpression of the Cre reporter TdTom, demonstrating hepatocyte origin, and ductular markers A6, OPN, and Sox9 (Figure 6, A–”
BackgroundResultInfluentialCholangiocytes act as facultative liver stem cells during impaired hepatocyte regeneration
Raven, A., Lu, W.-Y., Man, T. Y., Ferreira-Gonzalez, S., O’Duibhir, E., Dwyer, B. J., Thomson, J. P., Meehan, R. R., Bogorad, R., Koteliansky, V., et al. (2017) · Nature · doi:10.1038/nature23015 · Cited by 533
Robust cellular reprogramming occurs spontaneously during liver regeneration
Yanger, K., Zong, Y., Maggs, L. R., Shapira, S. N., Maddipati, R., Aiello, N. M., Thung, S. N., Wells, R. G., Greenbaum, L. E., & Stanger, B. Z. (2013) · Genes & Development · doi:10.1101/gad.207803.112 · Cited by 484
Damage-associated molecular patterns in cancer: a double-edged sword
Hernandez, C., Huebener, P., & Schwabe, R. F. (2016) · Oncogene · doi:10.1038/onc.2016.104 · Cited by 480 · cited 1×
“In addition to regulating sterile inflammation, it has been suggested that DAMPs may also be involved in repair responses, thereby linking cell death to wound healing responses such as regeneration and fibrogenesis and possibly also cancer development (38-40).”
BackgroundSelf-citationHepatic progenitor cells of biliary origin with liver repopulation capacity
Lu, W.-Y., Bird, T. G., Boulter, L., Tsuchiya, A., Cole, A. M., Hay, T., Guest, R. V., Wojtacha, D., Man, T. Y., Mackinnon, A., et al. (2015) · Nature Cell Biology · doi:10.1038/ncb3203 · Cited by 479 · cited 1×
“Recent studies in novel mouse models (21, 22) as well as data from zebrafish (19, 20) demonstrated a key contribution of the ductular compartment to liver regeneration in settings in which hepatocyte proliferation is efficiently blocked.”
BackgroundHe, G., Dhar, D., Nakagawa, H., Font-Burgada, J., Ogata, H., Jiang, Y., Shalapour, S., Seki, E., Yost, S. E., Jepsen, K., et al. (2013) · Cell · doi:10.1016/j.cell.2013.09.031 · Cited by 474 · cited 11×
“Consistent with previous studies (24, 25), we found via lineage tracing with AAV8-TBG-Cre that hepatocytes undergo ductular metaplasia, as seen by coexpression of the Cre reporter TdTom, demonstrating hepatocyte origin, and ductular markers A6, OPN, and Sox9 (Figure 6, A–”
BackgroundInfluentialVillanueva, A., Hoshida, Y., Battiston, C., Tovar, V., Sia, D., Alsinet, C., Cornella, H., Liberzon, A., Kobayashi, M., Kumada, H., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.02.006 · Cited by 447 · cited 5×
“High expression of these markers, reflecting poorly differentiated and stem cell-enriched tumors, has been correlated with poor clinical prognosis in a wide body of literature (29-36).”
BackgroundInfluentialFate tracing of mature hepatocytes in mouse liver homeostasis and regeneration
Malato, Y., Naqvi, S., Schürmann, N., Ng, R., Wang, B., Zape, J., Kay, M. A., Grimm, D., & Willenbring, H. (2011) · Journal of Clinical Investigation · doi:10.1172/jci59261 · Cited by 434 · cited 1×
“Although hepatocytes are the primary source for liver regeneration in multiple mouse models including those involving DDC or CDE diets, CCl4 injection, and partial hepatectomy (15, 16), these models do not achieve efficient suppression of hepatocyte proliferation and may not be ideal to test the contribution of ductul…”
BackgroundAdult Hepatocytes Are Generated by Self-Duplication Rather than Stem Cell Differentiation
Yanger, K., Knigin, D., Zong, Y., Maggs, L., Gu, G., Akiyama, H., Pikarsky, E., & Stanger, B. Z. (2014) · Cell Stem Cell · doi:10.1016/j.stem.2014.06.003 · Cited by 426 · cited 1×
“Although hepatocytes are the primary source for liver regeneration in multiple mouse models including those involving DDC or CDE diets, CCl4 injection, and partial hepatectomy (15, 16), these models do not achieve efficient suppression of hepatocyte proliferation and may not be ideal to test the contribution of ductul…”
BackgroundProgression of fibrosis in chronic hepatitis C
Ghany, M. G., Kleiner, D. E., Alter, H., Doo, E., Khokar, F., Promrat, K., Herion, D., Park, Y., Liang, T. J., & Hoofnagle, J. H. (2003) · Gastroenterology · doi:10.1053/gast.2003.50018 · Cited by 403
The HMGB1/RAGE axis triggers neutrophil-mediated injury amplification following necrosis
Huebener, P., Pradere, J.-P., Hernandez, C., Gwak, G.-Y., Caviglia, J. M., Mu, X., Loike, J. D., Jenkins, R. E., Antoine, D. J., & Schwabe, R. F. (2015) · Journal of Clinical Investigation · doi:10.1172/jci76887 · Cited by 354
Self-citationRuhl, C. E., & Everhart, J. E. (2009) · Gastroenterology · doi:10.1053/j.gastro.2008.10.052 · Cited by 352
Kim, H., Choi, G. H., Na, D. C., Ahn, E. Y., Kim, G. I., Lee, J. E., Cho, J. Y., Yoo, J. E., Choi, J. S., & Park, Y. N. (2011) · Hepatology · doi:10.1002/hep.24559 · Cited by 341
The HMGB1/RAGE axis triggers neutrophil-mediated injury amplification following necrosis
Huebener, P., Pradere, J.-P., Hernandez, C., Gwak, G.-Y., Caviglia, J. M., Mu, X., Loike, J. D., Jenkins, R. E., Antoine, D. J., & Schwabe, R. F. (2019) · Journal of Clinical Investigation · doi:10.1172/jci126975 · Cited by 300
Self-citationDisruption of TAK1 in hepatocytes causes hepatic injury, inflammation, fibrosis, and carcinogenesis
Inokuchi, S., Aoyama, T., Miura, K., Österreicher, C. H., Kodama, Y., Miyai, K., Akira, S., Brenner, D. A., & Seki, E. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909781107 · Cited by 279
Yang, X.-R., Xu, Y., Yu, B., Zhou, J., Qiu, S.-J., Shi, G.-M., Zhang, B.-H., Wu, W.-Z., Shi, Y.-H., Wu, B., et al. (2010) · Gut · doi:10.1136/gut.2008.176271 · Cited by 270
Chen, C., Lee, W., Yang, H., Chang, H., Jen, C., Iloeje, U. H., Su, J., Hsiao, C. K., Wang, L., You, S., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.06.036 · Cited by 268 · cited 2×
“Accordingly, chronic hepatocellular death strongly increases the risk for HCC development (6, 7).”
BackgroundIntratumoral neutrophils: A poor prognostic factor for hepatocellular carcinoma following resection
Li, Y.-W., Qiu, S.-J., Fan, J., Zhou, J., Gao, Q., Xiao, Y.-S., & Xu, Y.-F. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2010.07.044 · Cited by 268
Schaub, J. R., Malato, Y., Gormond, C., & Willenbring, H. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.07.003 · Cited by 254 · cited 1×
“Despite strong expansion of ductular cells, lineage tracing studies have shown that these cells do not significantly contribute to the generation of functional hepatocytes in the most commonly used models with a “progenitor response”, such as DDC and CDE diet as well as Mdr2 knockout mice, most likely due to the insuf…”
BackgroundHe, J., Lu, H., Zou, Q., & Luo, L. (2014) · Gastroenterology · doi:10.1053/j.gastro.2013.11.045 · Cited by 238 · cited 1×
“Recent studies in novel mouse models (21, 22) as well as data from zebrafish (19, 20) demonstrated a key contribution of the ductular compartment to liver regeneration in settings in which hepatocyte proliferation is efficiently blocked.”
BackgroundChoi, T., Ninov, N., Stainier, D. Y. R., & Shin, D. (2014) · Gastroenterology · doi:10.1053/j.gastro.2013.10.019 · Cited by 236 · cited 2×
“Recent studies in novel mouse models (21, 22) as well as data from zebrafish (19, 20) demonstrated a key contribution of the ductular compartment to liver regeneration in settings where hepatocyte proliferation is efficiently blocked.”
BackgroundTAK1 Suppresses a NEMO-Dependent but NF-κB-Independent Pathway to Liver Cancer
Bettermann, K., Vucur, M., Haybaeck, J., Koppe, C., Janssen, J., Heymann, F., Weber, A., Weiskirchen, R., Liedtke, C., Gassler, N., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.03.021 · Cited by 217
Hepatocellular carcinoma originates from hepatocytes and not from the progenitor/biliary compartment
Mu, X., Español-Suñer, R., Mederacke, I., Affò, S., Manco, R., Sempoux, C., Lemaigre, F. P., Adili, A., Yuan, D., Weber, A., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci77995 · Cited by 215 · cited 4×
“In murine models, in which HCC arises in response to carcinogens or in the setting of chronic injury, tumors originate from hepatocytes and not from ductular cells (26, 27).”
BackgroundInfluentialSelf-citationMDR3 (ABCB4) Defects: A Paradigm for the Genetics of Adult Cholestatic Syndromes
Trauner, M., Fickert, P., & Wagner, M. (2007) · Seminars in Liver Disease · doi:10.1055/s-2006-960172 · Cited by 214
Clinical Implications of Cancer Stem Cell Biology in Hepatocellular Carcinoma
Ji, J., & Wang, X. W. (2012) · Seminars in Oncology · doi:10.1053/j.seminoncol.2012.05.011 · Cited by 210 · cited 5×
“High expression of these markers, reflecting poorly differentiated and stem cell-enriched tumors, has been correlated with poor clinical prognosis in a wide body of literature (29-36).”
BackgroundInfluentialWon, C., Kim, B., Yi, E. H., Choi, K., Kim, E., Jeong, J., Lee, J., Jang, J., Yoon, J., Jeong, W., et al. (2015) · Hepatology · doi:10.1002/hep.27968 · Cited by 187
Wnt/β-catenin signaling mediates oval cell response in rodents
Apte, U., Thompson, M. D., Cui, S., Liu, B., Cieply, B., & Monga, S. P. S. (2008) · Hepatology · doi:10.1002/hep.21973 · Cited by 176
Animal models of biliary injury and altered bile acid metabolism
Mariotti, V., Strazzabosco, M., Fabris, L., & Calvisi, D. F. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.06.027 · Cited by 176
NFκB1 is a suppressor of neutrophil-driven hepatocellular carcinoma
Wilson, C. L., Jurk, D., Fullard, N., Banks, P., Page, A., Luli, S., Elsharkawy, A. M., Gieling, R. G., Chakraborty, J. B., Fox, C., et al. (2015) · Nature Communications · doi:10.1038/ncomms7818 · Cited by 171 · cited 1×
“Likewise, we did not find a role for HMGB1 in the recruitment of neutrophils (Figure 8D), a cell population that contributes to the development of liver cancer (60) and whose numbers positively correlate with worse prognosis in HCC (61, 62).”
BackgroundEthyl pyruvate decreases HMGB1 release and ameliorates murine colitis
Davé, S. H., Tilstra, J. S., Matsuoka, K., Li, F., DeMarco, R. A., Beer-Stolz, D., Sepulveda, A. R., Fink, M. P., Lotze, M. T., & Plevy, S. E. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.1008662 · Cited by 170
High mobility group box 1 orchestrates tissue regeneration via CXCR4
Tirone, M., Tran, N. L., Ceriotti, C., Gorzanelli, A., Canepari, M., Bottinelli, R., Raucci, A., Maggio, S. D., Santiago, C. A., Mellado, M., et al. (2017) · The Journal of Experimental Medicine · doi:10.1084/jem.20160217 · Cited by 166 · cited 2×
“(73) administered recombinant nonoxidizable HMGB1, whereas we deleted HMGB1.”
BackgroundResultWnt/β-Catenin Signaling in Murine Hepatic Transit Amplifying Progenitor Cells
Hu, M., Kurobe, M., Jeong, Y. J., Fuerer, C., Ghole, S., Nusse, R., & Sylvester, K. G. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.08.036 · Cited by 165
Tai, D., Lin, S., Sheen, I., Chu, C., Lin, D., & Liaw, Y. (2009) · Hepatology · doi:10.1002/hep.22878 · Cited by 164
Mei-Hsuan, L., Yang, H.-I., Lu, S.-N., Jen, C.-L., Yeh, S.-H., Liu, C.-J., Chen, P.-J., You, S.-L., Wang, L.-Y., Chen, W. J., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.29.1500 · Cited by 161
Boege, Y., Malehmir, M., Healy, M. E., Bettermann, K., Lorentzen, A., Vucur, M., Ahuja, A. K., Böhm, F., Mertens, J. C., Shimizu, Y., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.08.010 · Cited by 154
Lineage fate of ductular reactions in liver injury and carcinogenesis
Jörs, S., Jeliazkova, P., Ringelhan, M., Thalhammer, J., Dürl, S., Ferrer, J., Sander, M., Heikenwalder, M., Schmid, R. M., Siveke, J. T., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci78585 · Cited by 149 · cited 1×
“…the most commonly used models with a “progenitor response,” such as 3,5-diethoxycarbonyl-1,4-dihydrocollidine (DDC) and choline-deficient, ethionine-sup-plemented (CDE) diet–fed mice as well as Mdr2-knockout mice, most likely due to the insufficient suppression of hepatocyte proliferation (15–18).”
Arriazu, E., Ge, X., Leung, T.-M., Magdaleno, F., Lopategi, A., Lu, Y., Kitamura, N., Urtasun, R., Theise, N., Antoine, D. J., et al. (2017) · Gut · doi:10.1136/gutjnl-2015-310752 · Cited by 144 · cited 1×
“Our results on the role of HMGB1 in liver fibrosis also differ from those of a recently published study (74).”
ResultSelf-citationChen, R., Zhu, S., Fan, X., Wang, H., Lotze, M. T., Zeh, H. J., Billiar, T. R., Kang, R., & Tang, D. (2018) · Hepatology · doi:10.1002/hep.29663 · Cited by 142
Weber, A., Boger, R., Vick, B., Urbanik, T., Haybaeck, J., Zoller, S., Teufel, A., Krammer, P. H., Opferman, J. T., Galle, P. R., et al. (2010) · Hepatology · doi:10.1002/hep.23479 · Cited by 120 · cited 1×
“This concept is further supported by studies in mouse models with genetically-induced chronic hepatocyte death, such as mice with hepatocyte-specific deletion of Tak1, Nemo or Mcl-1, which spontaneously develop liver fibrosis and HCC (10-13), suggesting that chronic cell death is sufficient to initiate liver disease d…”
BackgroundCCN1 induces hepatic ductular reaction through integrin αvβ5–mediated activation of NF-κB
Kim, K.-H., Chen, C.-C., Alpini, G., & Lau, L. F. (2015) · Journal of Clinical Investigation · doi:10.1172/jci79327 · Cited by 109 · cited 1×
“This is consistent with findings that pathways such as β -catenin (66, 67), CCN1 (68), and FGF signaling (69) also promote ductular reactions in the liver.”
ResultLiver stem cells: experimental findings and implications for human liver disease
Michalopoulos, G. K., & Khan, Z. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.08.004 · Cited by 109 · cited 2×
“While this concept has been developed based on histopathological evidence in patients (14), the role of ductular cells in animal models remains a matter of debate (14).”
BackgroundHMGB1 promotes ductular reaction and tumorigenesis in autophagy-deficient livers
Khambu, B., Huda, N., Chen, X., Antoine, D. J., Li, Y., Dai, G., Köhler, U. A., Zong, W.-X., Waguri, S., Werner, S., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci91814 · Cited by 104
Self-citationTirnitz‐Parker, J. E. E., Tonkin, J. N., Knight, B., Olynyk, J. K., & Yeoh, G. C. (2007) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2007.06.008 · Cited by 103
Mutations in the Ras–Raf Axis Underlie the Prognostic Value of CD133 in Colorectal Cancer
Kemper, K., Versloot, M., Cameron, K., Colak, S., de Sousa e Melo, F., de Jong, J. H., Bleackley, J., Vermeulen, L., Versteeg, R., Koster, J., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-3066 · Cited by 101 · cited 1×
“This finding is supported by previous studies that have described a key role of Erk in the regulation of CD133 (54, 55).”
ResultPusterla, T., Nèmeth, J., Stein, I., Wiechert, L., Knigin, D., Marhenke, S., Longerich, T., Kumar, V., Arnold, B., Vogel, A., et al. (2013) · Hepatology · doi:10.1002/hep.26395 · Cited by 97
Cheng, B.-Q., Jia, C., Liu, C.-T., Lü, X., Zhong, N., Zhang, Z.-L., Fan, W.-J., & Li, Y. (2008) · Digestive and Liver Disease · doi:10.1016/j.dld.2007.11.024 · Cited by 96
Genetic lineage tracing analysis of the cell of origin of hepatotoxin‐induced liver tumors in mice
Shin, S., Wangensteen, K. J., Teta‐Bissett, M., Wang, Y. J., Mosleh‐Shirazi, E., Buza, E. L., Greenbaum, L. E., & Kaestner, K. H. (2016) · Hepatology · doi:10.1002/hep.28602 · Cited by 90 · cited 2×
“In murine models, in which HCC arises in response to carcinogens or in the setting of chronic injury, tumors originate from hepatocytes and not from ductular cells (26, 27).”
BackgroundHuebener, P., Gwak, G.-Y., Pradere, J.-P., Quinzii, C. M., Friedman, R., Lin, C.-S., Trent, C. M., Mederacke, I., Zhao, E., Dapito, D. H., et al. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.01.014 · Cited by 86
Evaluation of Patients With Hepatocellular Carcinomas That Do Not Produce α-Fetoprotein
Agopian, V. G., Harlander-Locke, M. P., Markovic, D., Zarrinpar, A., Kaldas, F. M., Cheng, E. Y., Yersiz, H., Farmer, D. G., Hiatt, J. R., & Busuttil, R. W. (2017) · JAMA Surgery · doi:10.1001/jamasurg.2016.3310 · Cited by 85
Kim, Y. M., Park, E., Kim, J. H., Park, S. W., Kim, H. J., & Chang, K. C. (2016) · International Immunopharmacology · doi:10.1016/j.intimp.2016.11.002 · Cited by 73
Tabu, K., Kimura, T., Sasai, K., Wang, L., Bizen, N., Nishihara, H., Taga, T., & Tanaka, S. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-39 · Cited by 70
Bak deficiency inhibits liver carcinogenesis: A causal link between apoptosis and carcinogenesis
Hikita, H., Kodama, T., Shimizu, S., Li, W., Shigekawa, M., Tanaka, S., Hosui, A., Miyagi, T., Tatsumi, T., Kanto, T., et al. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.01.027 · Cited by 64
Mu, X., Pradere, J.-P., Affò, S., Dapito, D. H., Friedman, R., Lefkovitch, J. H., & Schwabe, R. F. (2016) · Gastroenterology · doi:10.1053/j.gastro.2015.11.039 · Cited by 61
Self-citationEngelhardt, N. V., Factor, V. M., Medvinskiĭ, A. L., Baranov, V. N., Lazareva, M. N., & Poltoranina, V. S. (1993) · Differentiation · doi:10.1111/j.1432-0436.1993.tb00029.x · Cited by 51 · cited 1×
“Paraffin-embedded or frozen liver sections were stained with primary antibodies directed against A6 (76) (a gift of Dr.”
BackgroundVeldt, B. J., Hansen, B. E., Ikeda, K., Verhey, E., Suzuki, H., & Schalm, S. W. (2006) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520600641365 · Cited by 40 · cited 1×
“Glycyrrhizin, a phytochemical that inhibits HMGB1 (71), is widely used for the treatment of liver disease in Asia, and there are indications that glycyrrhizin can reduce HCC development in certain patient subsets (72).”
BackgroundUtley, S., James, D., Mavila, N., Nguyen, M. V., Vendryes, C., Salisbury, S. M., Phan, J., & Wang, K. S. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.12.017 · Cited by 33 · cited 1×
“This is consistent with findings that pathways such as β-catenin (66, 67), CCN1 (68), and FGF signaling (69) also promote ductular reactions in the liver.”
ResultHMGB1 promotes ductular reaction and tumorigenesis in autophagy-deficient livers
Khambu, B., Huda, N., Chen, X., Antoine, D. J., Li, Y., Dai, G., Köhler, U. A., Zong, W., Waguri, S., Werner, S., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci129234 · Cited by 10 · cited 1×
“Posttranslational modifications of HMGB1 were detected in mouse plasma with liquid chromatography tandem did not show alterations in liver fibrosis (75), further confirming our data.”
ResultSelf-citation
Cited by
Mechanisms of Fibrosis Development in Nonalcoholic Steatohepatitis
Schwabe, R. F., Tabas, I., & Pajvani, U. B. (2020) · Gastroenterology · doi:10.1053/j.gastro.2019.11.311 · Cited by 671
Self-citationApoptosis and necroptosis in the liver: a matter of life and death
Schwabe, R. F., & Luedde, T. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0065-y · Cited by 582
Self-citationInflammation and Liver Cancer: Molecular Mechanisms and Therapeutic Targets
Yang, Y., Kim, S., & Seki, E. (2019) · Seminars in Liver Disease · doi:10.1055/s-0038-1676806 · Cited by 449
The multifunctional protein HMGB1: 50 years of discovery
Tang, D., Kang, R., Zeh, H. J., & Lotze, M. T. (2023) · Nature Reviews Immunology · doi:10.1038/s41577-023-00894-6 · Cited by 371
“HMGB1 overexpression is commonly observed in multiple forms of cancer and has oncogenic effects, by enhancing anti-apoptotic mechanisms, inflammation, immune system evasion and aerobic glycolysis 117,118 .”
BackgroundMetal Drugs and the Anticancer Immune Response
Englinger, B., Pirker, C., Heffeter, P., Terenzi, A., Kowol, C. R., Keppler, B. K., & Berger, W. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00396 · Cited by 355
Metadata
- Authors
- Hernandez, C., Huebener, P., Pradere, J.-P., Antoine, D. J., Friedman, R. A., & Schwabe, R. F.
- Affiliations
- University Medical Center Hamburg-Eppendorf (DE)
- Centre for Inflammation Research (GB)
- Herbert Irving Comprehensive Cancer Center (US)
- Columbia University (US)
- Venue
- Journal of Clinical Investigation
- Published
- 2018-05-07
- Volume
- 128
- Issue
- 6
- Pages
- 2436-2451
- ISSN
- 0021-9738 (ISSN-L)
- 1558-8238
- PMC
- PMC5983315
- OpenAlex
- W2790482497
- Cited by
- 110
- References
- 85
- Citations by year
- 2026: 3 · 2025: 9 · 2024: 14 · 2023: 10 · 2022: 22 · 2021: 13 · 2020: 15 · 2019: 19 · 2018: 5
- FWCI
- 8.13
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- Locations
- Journal of Clinical Investigation (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Alcohol Abuse and Alcoholism (U01AA021912)
- National Cancer Institute (R01CA200597, P30CA013696)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK116620)
- Topics
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Medicine › Hepatology › Hepatocellular Carcinoma Treatment and Prognosis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
- Keywords
- HMGB1, chronic liver disease, hepatocellular carcinoma, hepatocarcinogenesis, hepatocyte death, damage-associated molecular patterns, ductular reaction, liver progenitor cells, liver fibrosis, liver regeneration, liver inflammation
- MeSH terms
- Animals, Child, Preschool, Chronic Disease, Female, Carcinoma, Hepatocellular, Humans, Liver, Liver Cirrhosis, Liver Neoplasms, Male, Neoplasm Proteins, Neoplastic Stem Cells, Hepatocytes, HMGB1 Protein, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.